Anti-Mesothelin Antibody (Anetumab)
Catalog No.
F2101
Anti-Mesothelin Antibody (Anetumab)
Featured Products
Anetumab is an antibody-drug conjugate (ADC) derived from the combination of a humanized monoclonal antibody and a cytotoxin. It consists of a humanized IgG1 monoclonal antibody and the tubulin inhibitor MMAE (monomethyl auristatin E). Anetumab works by targeting mesothelin, a cell surface protein that is highly expressed in a variety of cancers. Anetumab is used to treat mesothelin-positive malignancies, such as malignant pleural mesothelioma and certain types of ovarian cancer.
43.8 kDa
Dry ice
1954758-84-9
-80°C
2 years
Liquid
1 mg/mL
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Anetumab ravtansine
100 mM Pro 20 mM Arg pH 5.0.
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Mesothelin
Please avoid freeze-thaw cycles.